![Pierre Gianello](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierre Gianello
Direktor/Vorstandsmitglied bei
NYXOAH SA
Vermögen: 37 270 $ am 30.06.2026
Profil
Pierre Gianello is the founder of SYnAbs SA, which was founded in 2015.
He is currently a Director at Brussels Life Science Incubator SA and a Director at Pig For Life SA. He is also a Non-Executive Director at Nyxoah SA since 2018.
Dr. Gianello's former positions include being a Director at BruCells NV and Fetus For Life.
He was also a Professor at Katholieke Universiteit Leuven from 1997 to 2011.
Dr. Gianello holds a doctorate degree from Université Catholique de Louvain.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NYXOAH SA 0,02 % | 01.03.2026 | 21.560 ( 0,02 % ) | 37 270 $ | 30.06.2026 |
Aktive Positionen von Pierre Gianello
| Unternehmen | Position | Beginn |
|---|---|---|
| NYXOAH SA | Direktor/Vorstandsmitglied | 27.03.2018 |
Brussels Life Science Incubator SA
 Brussels Life Science Incubator SA Real Estate DevelopmentFinance Leases laboratory and medical research spaces for businesses | Direktor/Vorstandsmitglied | - |
Pig For Life SA
 Pig For Life SA Agricultural Commodities/MillingProcess Industries Engages in breeding pigs | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Pierre Gianello
| Unternehmen | Position | Ende |
|---|---|---|
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2011 |
Fetus For Life | Direktor/Vorstandsmitglied | - |
SynAbs SA
 SynAbs SA BiotechnologyHealth Technology Engages in producing custom rat and guinea pig monoclonal antibodies for pharmaceutical, biotech and in vitro diagnostic companies | Gründer | - |
BruCells NV
 BruCells NV Pharmaceuticals: MajorHealth Technology Develops therapeutic cancer vaccines | Direktor/Vorstandsmitglied | - |
Ausbildung von Pierre Gianello
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BruCells NV
BruCells NV Pharmaceuticals: MajorHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brussels Life Science Incubator SA
Brussels Life Science Incubator SA Real Estate DevelopmentFinance Leases laboratory and medical research spaces for businesses | Finance |
Nyxoah SA
 Nyxoah SA Medical SpecialtiesHealth Technology Manufactures neurostimulation devices for treating obstructive sleep apnea | Health Technology |
SynAbs SA
SynAbs SA BiotechnologyHealth Technology Engages in producing custom rat and guinea pig monoclonal antibodies for pharmaceutical, biotech and in vitro diagnostic companies | Health Technology |
Pig For Life SA
Pig For Life SA Agricultural Commodities/MillingProcess Industries Engages in breeding pigs | Process Industries |
Fetus For Life |
